This article is part of the supplement: Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
Gram-negative antibiotic resistance: there is a price to pay
-
Correspondence: Thomas G Slama slamaidi@aol.com
Critical Care 2008, 12(Suppl 4):S4 doi:10.1186/cc6820
No comments have yet been made on this article.